-
Catalyst, KYE Agree to Commercialize Firdapse for Adult LEMS Patients in Canada
Catalyst Pharmaceuticals and KYE Pharmaceuticals have reached an exclusive agreement to commercialize Firdapse in Canada. Click here to learn more.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.